Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite no difference in platelet count recovery End-of-Phase 2 ...
Parex Resources (TSE:PXT) used its fourth-quarter 2025 conference call to highlight operational execution in Colombia, ...
Bruising drops in software company stocks this year have left investors struggling to discern which firms will be least and most affected by competition from AI agents. “They’re trying to figure out ...
Thousands of tech workers have already lost their jobs this year and leaders at some companies say AI will enable employers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results